<DOC>
	<DOC>NCT00240747</DOC>
	<brief_summary>Open-label, multicenter, multiple-dose, study of population pharmacokinetics of I.V. Synercid (7.5 mg/kg every 8 hours) in 75 pediatric patients. The purpose is to assess the population pharmacokinetics of Synercid in pediatric patients and to collect additional safety and efficacy data in pediatric patients.</brief_summary>
	<brief_title>Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Quinupristin-dalfopristin</mesh_term>
	<criteria>Serious, suspected or documented grampositive infection</criteria>
	<gender>All</gender>
	<minimum_age>27 Weeks</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>